MyAverix Finance
SHG · Healthcare
Aurisco Pharmaceutical Co Ltd (605116)
Biotechnology
Aurisco Pharmaceutical Co Ltd (605116) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $10.84B, P/E ratio is 18.00, net margin is 26.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 605116
Aurisco Pharmaceutical Co Ltd (605116) — FAQ
What is Aurisco Pharmaceutical Co Ltd's market cap?
Aurisco Pharmaceutical Co Ltd (605116) has a reported market cap of $10.84B (data as of 2026-03-29).
What is 605116's P/E ratio?
The price-to-earnings (P/E) ratio for Aurisco Pharmaceutical Co Ltd (605116) is 18.00 (data as of 2026-03-29).
Does Aurisco Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Aurisco Pharmaceutical Co Ltd (605116). Check the MyAverix Finance app for the latest dividend data.
What sector is Aurisco Pharmaceutical Co Ltd in?
Aurisco Pharmaceutical Co Ltd (605116) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 605116 listed on?
605116 is listed on SHG.
What is Aurisco Pharmaceutical Co Ltd's net margin?
Aurisco Pharmaceutical Co Ltd (605116) reports a net margin of 26.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.